Terms: = Ovarian cancer AND ALK, CD246, ENSG00000171094, 238, Q9UM73, TFG/ALK AND Clinical Outcome
2 results:
1. Identification of anaplastic lymphoma kinase as a potential therapeutic target in ovarian cancer.
Ren H; Tan ZP; Zhu X; Crosby K; Haack H; Ren JM; Beausoleil S; Moritz A; Innocenti G; Rush J; Zhang Y; Zhou XM; Gu TL; Yang YF; Comb MJ
Cancer Res; 2012 Jul; 72(13):3312-23. PubMed ID: 22570254
[TBL] [Abstract] [Full Text] [Related]
2. Novel targeted therapeutics: inhibitors of MDM2, alk and PARP.
Yuan Y; Liao YM; Hsueh CT; Mirshahidi HR
J Hematol Oncol; 2011 Apr; 4():16. PubMed ID: 21504625
[TBL] [Abstract] [Full Text] [Related]
